SPLM (Sentry Petroleum) EBITDA Margin %: 0.00% (As of Nov. 2011)

What is Sentry Petroleum EBITDA Margin %?

Sentry Petroleum SPLM -99.00% EBITDA Margin % is 0.00% as of Nov. 2011.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Sentry Petroleum's EBITDA for the three months ended in Nov. 2011 was $-0.48 Mil. Sentry Petroleum's Revenue for the three months ended in Nov. 2011 was $0.00 Mil. Therefore, Sentry Petroleum's EBITDA margin for the quarter that ended in Nov. 2011 was 0.00%.

Sentry Petroleum (OTCPK:SPLM) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Sentry Petroleum EBITDA Margin % Related Terms

Sentry Petroleum EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Sentry Petroleum's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sentry Petroleum EBITDA Margin % Chart

Sentry Petroleum Annual Data

Trend

Feb06

Feb07

Feb08

Feb09

Feb10

Feb11

EBITDA Margin %

Get a 7-Day Free Trial

0.00

Sentry Petroleum Quarterly Data
	Feb07	May07	Aug07	Nov07	Feb08	May08	Aug08	Nov08	Feb09	May09	Aug09	Nov09	Feb10	May10	Aug10	Nov10	Feb11	May11	Aug11	Nov11
EBITDA Margin %	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

SPLM vs PGNPQ, SOIGF, MKSEF: EBITDA Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Sentry Petroleum's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sentry Petroleum EBITDA Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sentry Petroleum's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Sentry Petroleum's EBITDA Margin % falls into.

Save Embed

Sentry Petroleum EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Sentry Petroleum's EBITDA Margin % for the fiscal year that ended in Feb. 2011 is calculated as

EBITDA Margin %	=	EBITDA (A: Feb. 2011 )	/	Revenue (A: Feb. 2011 )
	=	-0.96	/	0
	=	%

Sentry Petroleum's EBITDA Margin % for the quarter that ended in Nov. 2011 is calculated as

EBITDA Margin %	=	EBITDA (Q: Nov. 2011 )	/	Revenue (Q: Nov. 2011 )
	=	-0.479	/	0
	=	%

Frequently Asked Questions Learn more about EBITDA Margin % →

What does a EBITDA Margin % of 0.00% mean?

Sentry Petroleum (SPLM) has a EBITDA Margin % of 0.00% as of Nov. 2011. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Sentry Petroleum and its competitors.

Is Sentry Petroleum's EBITDA Margin % too high?

Sentry Petroleum's current EBITDA Margin % is 0.00%.

How does Sentry Petroleum's EBITDA Margin % compare to PGNPQ and SOIGF?

Sentry Petroleum's EBITDA Margin % of 0.00% can be compared against companies in the Drug Manufacturers industry. The industry median EBITDA Margin % is 12.44. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EBITDA Margin % for a Drug Manufacturers company?

The median EBITDA Margin % among Drug Manufacturers companies is 12.44, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EBITDA Margin % mean?

A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Sentry Petroleum and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sentry Petroleum's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Sentry Petroleum stock overvalued right now?

Sentry Petroleum (SPLM) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EBITDA Margin % calculated?

EBITDA Margin % is calculated from a company's financial statements. For Sentry Petroleum (SPLM), the current EBITDA Margin % is 0.00% as of Nov. 2011. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sentry Petroleum Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies PGNPQ SOIGF MKSEF CEI ORIG GULTU PACD JSPRF NADL FOEAY PHXHF AWLCF ICD PES ARHVF SDRL GUKYF SDLP TDGCF SBR

Address 2801 Bickford Avenue, Suite 103-366, Snohomish, WA, USA, 98290

Website http://www.stemsy.com

Sentry Petroleum Ltd is engaged in the business of growing and distributing CBD oils, with a direct-to-consumer focus on products and services.